adjunctive treatment
Neurocrine Biosciences Reports Positive Phase 2 Results for Osavampator in Major Depressive Disorder
Neurocrine Biosciences; osavampator; Phase 2 results; major depressive disorder; AMPA-PAM; SAVITRI study; clinical trial; adjunctive treatment; depression; safety profile